← Browse by Condition
Medical Condition
postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8
Total Trials
4
Recruiting Now
4
Trial Phases
EARLY_Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8 sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 2
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
NCT04221893
Recruiting
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Enrollment
28 pts
Location
United States
Sponsor
University of California, San ...
NCT05041153 EARLY_Phase 1
Recruiting
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
Enrollment
15 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT04660760 Phase 2
Recruiting
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
Enrollment
116 pts
Location
United States
Sponsor
Academic and Community Cancer ...
NCT04511039 Phase 1
Recruiting
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Enrollment
45 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology